Aprotinin is associated with a 50 per cent increase in the relative risk of death, according to a major Canadian clinical trial comparing three drugs routinely used to prevent blood loss during heart surgery.
Ads by Google
Disease and Condition
Scientists have developed the first genetically altered monkey model that replicates some symptoms observed in patients with Huntington's disease.
The National Spasmodic Torticollis Association has started a campaign with Mission Fish to raise funds for Spasmodic Torticollis treatment search.
BARRX Medical announced that 90.2 percent of the patients in a multi-center US study were free of the highest-risk of Barrett's esophagus after having a non-surgical, endoscopic treatment using the HALO360 ablation system.
Innovative prism glasses can significantly improve the vision and the daily lives of patients with hemianopia, a condition that blinds half the visual field in both eyes. The peripheral prism glasses, which were invented by Dr. Eli Peli, a Senior Scientist at Schepens Eye Research Institute, were evaluated in the first community-based multi- center trial of such a device, which is published in the May issue of the Archives of Ophthalmology. The study was coordinated by Dr. Alex Bowers, a Senior Scientific Associate at the Institute.
Innovative therapy is safe and slows Batten disease progression.
Restless legs syndrome treatment finds that although drug therapy using nonergot dopamine agonists reduces the severity of symptoms of restless legs syndrome , significant numbers of patients discontinue their use because of adverse side effects, including nausea, dizziness, drowsiness and fatigue.
Genzyme reported that a preliminary analysis of data from an ongoing open-label Phase 2 clinical trial of its investigational oral therapy Genz-112638 showed that the compound produced a meaningful impact on key clinical manifestations of Gaucher disease.
Drug botulinum toxin is safe and effective for treating cervical dystonia, a condition of involuntary head tilt or neck movement, spasticity and other forms of muscle overactivity that interfere with movement in adults and children with an upper motor neuron syndrome, and excessive sweating of the armpits and hands.
More medical experts will be sent to China's east Anhui Province to assist with local hand-foot-mouth disease (HFMD) relief work, according to Minister of Health Chen Zhu on Tuesday.
Panorama, covering hospital infections in UK, ran a terrifying story about the problem for hospitals posed by the c-diff superbug which is now killing about 6,000 patients a year in British hospitals - worse than MRSA.
A novel cell therapy using retinal pigment epithelial cells attached to tiny gelatin bead microcarriers implanted in the brain can improve the symptoms of patients with moderate to advanced Parkinson's disease.
When suffering through a sinus infection, many people ask for an antibiotic to speed their recovery. However, a recent review of clinical trials found that while antibiotics can provide minor improvements in uncomplicated sinusitis cases, most patients recover without the drugs within two weeks.
The health risks for the individual and society might override the benefits of antibiotics for people suffering with a simple sinus infection, according to authors led by Anneli Ahovuo-Saloranta of the Finnish Office for Health Technology.
Short-term replacement of renal cell function with renal tubule assist device speeds recovery, reduces mortality risk by 50 %.
Botulinum neurotoxin - responsible for the deadly food poisoning disease botulism and for the beneficial effects of smoothing out facial wrinkles - can also be used as a dreaded biological weapon.
Mutation which causes pyruvate kinase deficiency - a genetic disorder of blood cells - protects its carriers against malaria.
Naturally elevated levels of the antioxidant urate may slow the progression of Parkinson's disease in men. Researchers from the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) and Harvard School of Public Health (HSPH) examined data from an earlier study and found that, among recently diagnosed Parkinson's patients, those with the highest urate levels had a significantly slower rate of disease progression during the two-year study period.
CHMP of the European Medicines Agency has adopted a positive opinion recommending approval of ranolazine in EU for the treatment of chronic angina.
Compared to older drugs for Parkinson disease, a newer class of medications called dopamine agonists might be better at preventing some of the disabling muscle control problems associated with the disease and its treatment.
- « first
- ‹ previous
- next ›
- last »